This infographic was developed as a continuation of the ‘SGLT2 inhibitors and renal protection: Interpreting the latest guidance for patients with hypertension in CKD’ symposium which took place at the 2023 European Society of Hypertension (ESH) congress. It summarises the ESH guidelines for the use of SGLT2 inhibitors in patients with hypertension, and the evidence that contributed to these recommendations.